• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHI
Click for more information
2.84% $1.81

Channel Infrastructure NZ Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Energy Oil & Gas Midstream

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHI
Ann: Biorefinery proposed at Marsden Point Energy Precinct 		01/10/24 0 90
01/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  90 
CHI
Ann: HY24 Results 		23/08/24 0 156
23/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  156 
CHI
Ann: Q2 2024 Operational Update 		15/07/24 0 171
15/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  171 
CHI
Ann: Update on sale of decommissioned assets 		05/07/24 0 150
05/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  150 
CHI
Ann: HY24 Results Date 		05/07/24 0 187
05/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  187 
CHI
Ann: CHI presentation to Rapid Insights Conference 		26/06/24 0 141
26/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  141 
CHI
Ann: SPH Notice - BP New Zealand Holdings Limited ("BPNZ") 		21/06/24 0 127
21/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  127 
CHI
Ann: SPH Notice - Milford Asset Management Limited 		21/06/24 0 108
21/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  108 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Most viewed thread today: Rio Tinto confirms approach to Arcadium Lithium
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
NEWS High-grade gold discovery at Didievi Project: First drill results reveal impressive 33m intercept at 2.4g/t
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
(20min delay)
Last
$1.81 		Change
0.050(2.84%) 		Mkt cap ! n/a
Open High Low Value Volume
$1.80 $1.81 $1.79 $285.5K 158.5K

Buyers (Bids)

No. Vol. Price($)
0 9719 $1.79
 

Sellers (Offers)

Price($) Vol. No.
$1.82 15000 0
Last trade - 13.00pm 07/10/2024 (20 minute delay) ?
CHI (NZSX) Chart

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.
Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome Neuren has confirmed it's received "positive" FDA responses for its Phase III trial to treat children with Phelan-McDermid syndrome.
Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program Arika Resources Ltd has received commitments from investors in support of a Placement worth $3.2 million to support gold exploration in WA
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03 Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage

Featured News

NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.